301 related articles for article (PubMed ID: 25960425)
1. Comparison of the effectiveness of four antiepileptic drugs in the treatment of status epilepticus according to four different efficacy criteria.
Redecker J; Wittstock M; Benecke R; Rösche J
Epilepsy Behav; 2015 Aug; 49():351-3. PubMed ID: 25960425
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of different kinds of intravenously applied antiepileptic drugs in the treatment of status epilepticus. How can it be determined?
Redecker J; Wittstock M; Rösche J
Epilepsy Behav; 2017 Jun; 71(Pt A):35-38. PubMed ID: 28460320
[TBL] [Abstract][Full Text] [Related]
3. Treatment and course of different subtypes of status epilepticus.
Rantsch K; Walter U; Wittstock M; Benecke R; Rösche J
Epilepsy Res; 2013 Nov; 107(1-2):156-62. PubMed ID: 24016689
[TBL] [Abstract][Full Text] [Related]
4. Intravenous antiepileptic drugs in adults with benzodiazepine-resistant convulsive status epilepticus: A systematic review and network meta-analysis.
Brigo F; Del Giovane C; Nardone R; Trinka E; Lattanzi S
Epilepsy Behav; 2019 Dec; 101(Pt B):106466. PubMed ID: 31462385
[TBL] [Abstract][Full Text] [Related]
5. Treatment of benzodiazepine-refractory status epilepticus: A retrospective, cohort study.
Rollo E; Romozzi M; Dono F; Bernardo D; Consoli S; Anzellotti F; Ricciardi L; Paci L; Sensi SL; Della Marca G; Servidei S; Calabresi P; Vollono C
Epilepsy Behav; 2023 Mar; 140():109093. PubMed ID: 36739634
[TBL] [Abstract][Full Text] [Related]
6. A comparison of four antiepileptic drugs in status epilepticus: experience from India.
Misra UK; Kalita J
Int J Neurosci; 2016 Nov; 126(11):1013-9. PubMed ID: 26456955
[TBL] [Abstract][Full Text] [Related]
7. Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy.
Santamarina E; González-Cuevas M; Toledo M; Jiménez M; Becerra JL; Quílez A; Suller A; Mauri JA; Fernández Á; Marinas A; Quintana M; Puig XS
Epilepsy Behav; 2018 Jul; 84():93-98. PubMed ID: 29758445
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus.
Sánchez Fernández I; Gaínza-Lein M; Lamb N; Loddenkemper T
Neurology; 2019 May; 92(20):e2339-e2348. PubMed ID: 31068480
[TBL] [Abstract][Full Text] [Related]
9. Comparing the efficacy of sodium valproate and levetiracetam following initial lorazepam in elderly patients with generalized convulsive status epilepticus (GCSE): A prospective randomized controlled pilot study.
Nene D; Mundlamuri RC; Satishchandra P; Prathyusha PV; Nagappa M; Bindu PS; Raghavendra K; Saini J; Bharath RD; Thennarasu K; Taly AB; Sinha S
Seizure; 2019 Feb; 65():111-117. PubMed ID: 30682680
[TBL] [Abstract][Full Text] [Related]
10. Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam--Pilot study.
Mundlamuri RC; Sinha S; Subbakrishna DK; Prathyusha PV; Nagappa M; Bindu PS; Taly AB; Umamaheswara Rao GS; Satishchandra P
Epilepsy Res; 2015 Aug; 114():52-8. PubMed ID: 26088885
[TBL] [Abstract][Full Text] [Related]
11. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
Kellinghaus C; Berning S; Stögbauer F
Acta Neurol Scand; 2014 May; 129(5):294-9. PubMed ID: 23937330
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of perampanel in refractory nonconvulsive status epilepticus and simple partial status epilepticus.
Redecker J; Wittstock M; Benecke R; Rösche J
Epilepsy Behav; 2015 Apr; 45():176-9. PubMed ID: 25819947
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of intravenous lacosamide in status epilepticus.
Santamarina E; Toledo M; Sueiras M; Raspall M; Ailouti N; Lainez E; Porta I; De Gracia R; Quintana M; Alvarez-Sabín J; Xavier Salas Puig XS
J Neurol; 2013 Dec; 260(12):3122-8. PubMed ID: 24122063
[TBL] [Abstract][Full Text] [Related]
14. Observational study of intravenous lacosamide in patients with convulsive versus non-convulsive status epilepticus.
Moreno Morales EY; Fernandez Peleteiro M; Bondy Peña EC; Domínguez Lorenzo JM; Pardellas Santiago E; Fernández A
Clin Drug Investig; 2015 Jul; 35(7):463-9. PubMed ID: 26108190
[TBL] [Abstract][Full Text] [Related]
15. Newer Antiepileptic Drugs in Status Epilepticus: Prescription Trends and Outcomes in Comparison with Traditional Agents.
Beuchat I; Novy J; Rossetti AO
CNS Drugs; 2017 Apr; 31(4):327-334. PubMed ID: 28337727
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
Sutter R; Marsch S; Rüegg S
CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
[TBL] [Abstract][Full Text] [Related]
17. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus.
Brigo F; Bragazzi N; Nardone R; Trinka E
Epilepsy Behav; 2016 Nov; 64(Pt A):110-115. PubMed ID: 27736657
[TBL] [Abstract][Full Text] [Related]
18. Why we prefer levetiracetam over phenytoin for treatment of status epilepticus.
Zaccara G; Giorgi FS; Amantini A; Giannasi G; Campostrini R; Giovannelli F; Paganini M; Nazerian P;
Acta Neurol Scand; 2018 Jun; 137(6):618-622. PubMed ID: 29624640
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam versus phenytoin in management of status epilepticus.
Chakravarthi S; Goyal MK; Modi M; Bhalla A; Singh P
J Clin Neurosci; 2015 Jun; 22(6):959-63. PubMed ID: 25899652
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study.
Garcés M; Villanueva V; Mauri JA; Suller A; García C; López González FJ; Rodríguez Osorio X; Fernández Pajarín G; Piera A; Guillamón E; Santafé C; Castillo A; Giner P; Torres N; Escalza I; Del Villar A; García de Casasola MC; Bonet M; Noé E; Olmedilla N
Epilepsy Behav; 2014 Jul; 36():144-52. PubMed ID: 24922617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
